Do new devices add to the results of PTCA in acute myocardial infarction?
- 31 August 1999
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 138 (2) , S158-S163
- https://doi.org/10.1016/s0002-8703(99)70337-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial InfarctionNew England Journal of Medicine, 1997
- Deleterious Effects of a Systemic Lytic State on Reperfused MyocardiumCirculation, 1995
- Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial InfarctionCirculation, 1995
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.Circulation, 1993
- Immediate Angioplasty Compared with the Administration of a Thrombolytic Agent Followed by Conservative Treatment for Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988